Advances in the management of idiosyncratic drug-induced liver injury.
Journal
Clinical liver disease
ISSN: 2046-2484
Titre abrégé: Clin Liver Dis (Hoboken)
Pays: United States
ID NLM: 101597441
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
10
04
2023
accepted:
10
04
2023
medline:
8
11
2023
pubmed:
8
11
2023
entrez:
8
11
2023
Statut:
epublish
Résumé
1_pff0548qKaltura.
Identifiants
pubmed: 37936954
doi: 10.1097/CLD.0000000000000052
pmc: PMC10627588
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102-106Informations de copyright
Copyright © 2023 American Association for the Study of Liver Diseases.
Déclaration de conflit d'intérêts
The authors have no conflicts to report.
Références
Hepatology. 2002 Aug;36(2):451-5
pubmed: 12143055
Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20
pubmed: 23419359
Gastroenterology. 2009 Sep;137(3):856-64, 864.e1
pubmed: 19524577
Br J Clin Pharmacol. 2005 Jul;60(1):76-82
pubmed: 15963097
Gastroenterology. 2011 Jul;141(1):338-47
pubmed: 21570397
Hepatology. 2021 Jan;73(1):268-281
pubmed: 32270503
J Clin Rheumatol. 2009 Dec;15(8):389-92
pubmed: 19955995
J Hepatol. 2019 Jun;70(6):1222-1261
pubmed: 30926241
J Hepatol. 2022 May;76(5):1070-1078
pubmed: 35074471
Hepatology. 2022 Jul;76(1):18-31
pubmed: 35014066
Ann Intern Med. 2002 Dec 17;137(12):947-54
pubmed: 12484709
Clin Exp Dermatol. 2015 Dec;40(8):851-9
pubmed: 26271788
Hepatology. 2010 Jun;51(6):2117-26
pubmed: 20512999
Ann Pharmacother. 2010 Jul-Aug;44(7-8):1287-93
pubmed: 20587742